Literature DB >> 19454669

Cooperation between molecular targets of costimulation in promoting T cell persistence and tumor regression.

Baohua Zhao1, Aihua Song, Rizwanul Haque, Fengyang Lei, Lauren Weiler, Xiaofang Xiong, Yuzhang Wu, Michael Croft, Jianxun Song.   

Abstract

Costimulation regulates multiple cellular processes of T cells inducing proliferation, expansion, and survival. The molecular targets of costimulation might then be useful to augment T cell activities. Two defined targets of costimulatory signals in primary T cells are the anti-apoptotic bcl-2 family molecule Bcl-x(L), and survivin, an inhibitor of apoptosis family member that might regulate both cell division and survival. However, the relative importance of, and relationship between, these molecules in primary T cells is not clear. To understand whether they have overlapping or cooperative functions, we used retrovirus-mediated transduction to introduce Bcl-x(L) and survivin separately, or together linked by a 2A picornavirus self-cleaving peptide, into Ag-responding CD8(+) T cells. We found that CD8(+) effector T cells expressing both Bcl-x(L) and survivin strongly expanded at an early stage and had a long-term survival advantage over cells transduced with either molecule alone. In vivo, with response to tumor-expressed Ag following adoptive T cell transfer, Ag-reactive CD8(+) T cells expressing both Bcl-x(L) and survivin displayed greatly enhanced tumor protective activity compared with CD8(+) T cells expressing either molecule introduced separately. These results indicate that Bcl-x(L) and survivin can critically contribute in a cooperative, nonredundant manner to augment the accumulation and persistence of CD8(+) T cells following encounter with Ag. The data provide new insights into why costimulatory signals might need to be sustained over time and suggest a potential novel approach to augment cellular immunotherapy for cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19454669      PMCID: PMC2748393          DOI: 10.4049/jimmunol.0804387

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  New B7 family members with positive and negative costimulatory function.

Authors:  Cecilia Rietz; Lieping Chen
Journal:  Am J Transplant       Date:  2004-01       Impact factor: 8.086

2.  Co-translational, intraribosomal cleavage of polypeptides by the foot-and-mouth disease virus 2A peptide.

Authors:  Pablo de Felipe; Lorraine E Hughes; Martin D Ryan; Jeremy D Brown
Journal:  J Biol Chem       Date:  2003-01-08       Impact factor: 5.157

3.  Lymphotoxin-mediated regulation of gammadelta cell differentiation by alphabeta T cell progenitors.

Authors:  Bruno Silva-Santos; Daniel J Pennington; Adrian C Hayday
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

Review 4.  TNF/TNFR family members in costimulation of T cell responses.

Authors:  Tania H Watts
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

5.  4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.

Authors:  Wojciech Dawicki; Edward M Bertram; Arlene H Sharpe; Tania H Watts
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

Review 6.  The roles of the new negative T cell costimulatory pathways in regulating autoimmunity.

Authors:  Samia J Khoury; Mohamed H Sayegh
Journal:  Immunity       Date:  2004-05       Impact factor: 31.745

7.  The costimulation-regulated duration of PKB activation controls T cell longevity.

Authors:  Jianxun Song; Shahram Salek-Ardakani; Paul R Rogers; Mary Cheng; Luk Van Parijs; Michael Croft
Journal:  Nat Immunol       Date:  2004-01-18       Impact factor: 25.606

8.  Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector.

Authors:  Andrea L Szymczak; Creg J Workman; Yao Wang; Kate M Vignali; Smaroula Dilioglou; Elio F Vanin; Dario A A Vignali
Journal:  Nat Biotechnol       Date:  2004-04-04       Impact factor: 54.908

9.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Authors:  Susan M Kaech; Joyce T Tan; E John Wherry; Bogumila T Konieczny; Charles D Surh; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-11-16       Impact factor: 25.606

10.  Memory CD8+ T cells mediate antibacterial immunity via CCL3 activation of TNF/ROI+ phagocytes.

Authors:  Emilie Narni-Mancinelli; Laura Campisi; Delphine Bassand; Julie Cazareth; Pierre Gounon; Nicolas Glaichenhaus; Grégoire Lauvau
Journal:  J Exp Med       Date:  2007-08-13       Impact factor: 14.307

View more
  12 in total

1.  Role of interferon-γ and cytotoxic T lymphocytes in intraocular tumor rejection.

Authors:  Ann J Ligocki; Joseph R Brown; Jerry Y Niederkorn
Journal:  J Leukoc Biol       Date:  2015-11-17       Impact factor: 4.962

2.  Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammation.

Authors:  Fengyang Lei; Jianyong Song; Rizwanul Haque; Xiaofang Xiong; Deyu Fang; Yuzhang Wu; Susanne M A Lens; Michael Croft; Jianxun Song
Journal:  Eur J Immunol       Date:  2013-05-28       Impact factor: 5.532

3.  FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development.

Authors:  Rizwanul Haque; Fengyang Lei; Xiaofang Xiong; Yuzhang Wu; Jianxun Song
Journal:  Arthritis Res Ther       Date:  2010-04-12       Impact factor: 5.156

4.  IFN-γ upregulates survivin and Ifi202 expression to induce survival and proliferation of tumor-specific T cells.

Authors:  Mary Zimmerman; Dafeng Yang; Xiaolin Hu; Feiyan Liu; Nagendra Singh; Darren Browning; Vadivel Ganapathy; Phillip Chandler; Divaker Choubey; Scott I Abrams; Kebin Liu
Journal:  PLoS One       Date:  2010-11-22       Impact factor: 3.240

5.  Melanoma Immunotherapy in Mice Using Genetically Engineered Pluripotent Stem Cells.

Authors:  Mohammad Haque; Jianyong Song; Kristin Fino; Praneet Sandhu; Youfei Wang; Bing Ni; Deyu Fang; Jianxun Song
Journal:  Cell Transplant       Date:  2016-01-15       Impact factor: 4.064

6.  Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HIV Replication and PD-1 Expression on CD4+ T Cells.

Authors:  Mohammad Haque; Fengyang Lei; Xiaofang Xiong; Yijie Ren; Hao-Yun Peng; Liqing Wang; Anil Kumar; Jugal Kishore Das; Jianxun Song
Journal:  Viruses       Date:  2021-04-25       Impact factor: 5.048

7.  c-Myc-Induced Survivin Is Essential for Promoting  the Notch-Dependent T Cell Differentiation from  Hematopoietic Stem Cells.

Authors:  Rizwanul Haque; Jianyong Song; Mohammad Haque; Fengyang Lei; Praneet Sandhu; Bing Ni; Songguo Zheng; Deyu Fang; Jin-Ming Yang; Jianxun Song
Journal:  Genes (Basel)       Date:  2017-03-06       Impact factor: 4.096

8.  Protective Cancer Vaccine Using Genetically Modified Hematopoietic Stem Cells.

Authors:  Xiaofang Xiong; Jugal Kishor Das; Jianyong Song; Bing Ni; Xingcong Ren; Jin-Ming Yang; Jianxun Song
Journal:  Vaccines (Basel)       Date:  2018-07-06

9.  Regulation of A1 by OX40 contributes to CD8(+) T cell survival and anti-tumor activity.

Authors:  Fengyang Lei; Jianyong Song; Rizwanul Haque; Mohammad Haque; Xiaofang Xiong; Deyu Fang; Michael Croft; Jianxun Song
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

10.  C-Myc regulation by costimulatory signals modulates the generation of CD8+ memory T cells during viral infection.

Authors:  Mohammad Haque; Jianyong Song; Kristin Fino; Youfei Wang; Praneet Sandhu; Xinmeng Song; Christopher Norbury; Bing Ni; Deyu Fang; Shahram Salek-Ardakani; Jianxun Song
Journal:  Open Biol       Date:  2016-01       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.